Healthcare,Tech & Payments eClinical solutions for the pharmaceutical industry
James Corrigan, CEO
Waqar Nasim, CFO
Chairman of the Board
ERT's systems are widely used by pharmaceutical and biotech companies innovating drug and device therapies to optimize clinical trial management, and to document safety and efficacy clinical outcomes data.
Since its inception in 1972, ERT has developed from a technology start-up to a company that today supports the conduct of more than 1,500 clinical trials annually. This is achieved through the compilation of a variety of clinical outcome data from more than 2.7 million patients, in strict accordance with the standards defined by the major regulatory agencies.
Nordic Capital's ambition is to support ERT's continued development, strategic goals, future growth and further international expansion. Supported by Nordic Capital, ERT will be well positioned to continue its development as a global market leader within innovative and differentiated patient data collection solutions.
EUR 330 million
Nordic Capital Fund VIII, controlling shareholding
Philadelphia, Pennsylvania, USA